Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Friday, October 31, 2025.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2025-10-31): -167.14%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-178.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-214.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
HeartSciences Inc.
Market Cap
$7.90M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-178.18%
3Y Avg
-214.51%
5Y Avg
N/A
Market Cap
$7.86M
Return on Invested Capital (ROIC)
-92.94%
TTM Avg
-279.36%
3Y Avg
-244.50%
5Y Avg
-201.18%
Market Cap
$7.97M
Return on Invested Capital (ROIC)
-457.75%
TTM Avg
-214.65%
3Y Avg
-192.14%
5Y Avg
-209.63%
Market Cap
$8.00M
Return on Invested Capital (ROIC)
-92.93%
TTM Avg
-227.52%
3Y Avg
-201.78%
5Y Avg
-175.64%
Market Cap
$8.14M
Return on Invested Capital (ROIC)
-33.73%
TTM Avg
-84.97%
3Y Avg
-168.83%
5Y Avg
-136.52%
Market Cap
$8.30M
Return on Invested Capital (ROIC)
-439.90%
TTM Avg
-355.30%
3Y Avg
-355.30%
5Y Avg
-355.30%
Market Cap
$7.43M
Return on Invested Capital (ROIC)
-211.58%
TTM Avg
-206.45%
3Y Avg
-187.44%
5Y Avg
-143.49%
Market Cap
$7.31M
Return on Invested Capital (ROIC)
-995.44%
TTM Avg
-481.38%
3Y Avg
-268.85%
5Y Avg
-219.77%
Market Cap
$7.28M
Return on Invested Capital (ROIC)
-232.05%
TTM Avg
-321.25%
3Y Avg
-211.94%
5Y Avg
-167.22%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartSciences Inc. (HSCS) | $7.90M | N/A | -178.18% | -214.51% | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.86M | -92.94% | -279.36% | -244.50% | -201.18% |
| GT Biopharma, Inc. (GTBP)vs › | $7.97M | -457.75% | -214.65% | -192.14% | -209.63% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $8.00M | -92.93% | -227.52% | -201.78% | -175.64% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.14M | -33.73% | -84.97% | -168.83% | -136.52% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.30M | -439.90% | -355.30% | -355.30% | -355.30% |
| Longeveron Inc. (LGVN)vs › | $7.43M | -211.58% | -206.45% | -187.44% | -143.49% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -995.44% | -481.38% | -268.85% | -219.77% |
| KALA BIO, Inc. (KALA)vs › | $7.28M | -232.05% | -321.25% | -211.94% | -167.22% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.53M | -21.90% | -47.33% | -176.82% | -106.87% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-10-31 | -167.14% |
| 2025-07-31 | -164.21% |
| 2025-04-30 | -271.99% |
| 2025-01-31 | -178.42% |
| 2024-10-31 | -109.13% |
| 2024-07-31 | -103.09% |
| 2024-04-30 | -76.42% |
| 2024-01-31 | -62.79% |
| 2023-10-31 | -2283.89% |
| 2023-07-31 | -501.11% |
| 2023-04-30 | -312.79% |
| 2023-01-31 | -399.54% |
| 2022-10-31 | -227.49% |
| 2022-07-31 | -131.52% |
| 2022-04-30 | -1892.25% |